Therapeutic Expansion Avania is expanding its internal therapeutic leadership with a newly appointed Chief Medical Officer in 2026, signaling growing capacity to support sponsors across design, execution, and commercialization of medical device and combination product trials.

Leadership Growth Recent high-level hires in global business development and executive leadership (Sr. VP roles, COO, President/CEO) indicate a strategic push to scale client acquisition, strategic partnerships, and global market access initiatives.

Global Reach Positioned as a leading global MedTech advisory and clinical development partner with multi-region presence (e.g., Netherlands, Boston), presenting opportunities to offer cross-border regulatory, reimbursement, and post-market strategies to sponsors.

Early stage to Post-market Capabilities span feasibility through post-market trials, enabling a one-stop CRO proposition for clients seeking end-to-end support from initial study design to market access and payer strategies.

Tech and Tools Utilizes a mix of popular enterprise tools (Salesforce, iCIMS, Smartsheet, WordPress, Smartsheet, analytics platforms) that can be leveraged to demonstrate efficient study management, data handling, and client collaboration to prospective sponsors.